An Assessment of the Impact of Informative Dropout and Nonresponse in Measuring Health-Related Quality of Life Using the EuroQol (EQ-5D) Descriptive System  by Ratcliffe, Julie et al.
 Volume 8 • Number 1 • 2005
V A L U E  I N  H E A L T H
 
© ISPOR 1098-3015/05/53 53–58
 
53
 
Blackwell Science, LtdOxford, UK
 
VHEValue in Health1098-30152005 ISPOR
 
January/February 2005815358
 
Original Article
 
Informative Dropout and Nonresponse ImpactRatcliffe et al.
 
Address correspondence to:
 
 Julie Ratcliffe, Shefﬁeld Health
Economics Group, School of Health and Related Research,
University of Shefﬁeld, Regent Court 30, Regent Street,
Shefﬁeld S1 4DA, UK. E-mail: j.ratcliffe@shefﬁeld.ac.uk
 
An Assessment of the Impact of Informative Dropout and 
Nonresponse in Measuring Health-Related Quality of Life 
Using the EuroQol (EQ-5D) Descriptive System
 
Julie Ratcliffe, PhD,
 
1
 
 Tracey Young, MSc,
 
2
 
 Louise Longworth, MSc,
 
2
 
 Martin Buxton, BA
 
2
 
1
 
School of Health and Related Research, University of Shefﬁeld, Shefﬁeld, UK; 
 
2
 
Health Economics Research Group, Brunel University, 
Uxbridge, UK
 
ABSTRACT
 
Objectives:
 
To investigate the impact of imputing EQ-5D
values to allow for informative dropout and nonresponse
in a longitudinal assessment of the health-related quality
of life (HRQL) of liver transplant recipients.
Methods: The EQ-5D was administered at deﬁned time
intervals pre- and post-transplantation to all adults who
were listed to receive liver transplants as National Health
Service (NHS) treatment at each of the six Department of
Health designated centers in England and Wales over a
time-period of 36 months (12 month recruitment period
and 24 month follow-up period). During the course of the
study missing data arose for two main reasons, informa-
tive dropout and nonresponse. Informative dropout was
accounted for by giving those patients who died an EQ-
5D score of 0 and those patients who were too ill to
respond to an EQ-5D score equivalent to the 5th percen-
tile of respondents for each time point pretransplantation.
Nonresponse was accounted for using relatively naïve
approaches (last value carried forward, and upper/lower
95% conﬁdence interval around the mean) and con-
trasted with a more sophisticated multiple imputation
method.
Results: Adjusting for informative dropout in isolation
resulted in a marked deterioration in mean scores over
time pretransplant relative to the base case situation in
which no such adjustments were made. Nevertheless,
adjusting for informative dropout and/or nonresponders
did not alter the base case conclusion of no statistically
signiﬁcant differences in mean EQ-5D scores over time
pretransplant. In contrast, post-transplant data indicated
highly statistically signiﬁcant improvements in quality of
life over time for the base case (P < 0.001) whereas no sta-
tistically signiﬁcant improvements over time were found
when informative dropout was allowed for in isolation
(P = 0.402) or when informative dropout and nonre-
sponse were allowed for simultaneously (P = 0.105–
0.185).
Conclusions: It is important that future studies which
purport to assess the HRQL over time of patients, such as
these with end-stage liver disease, include an allowance
for informative dropout and nonresponse within the
analysis.
Keywords: EQ-5D, informative dropout, liver transplan-
tation, quality of life.
 
Introduction
 
The measurement of health-related quality of life
(HRQL) is an essential component of any cost util-
ity analysis (CUA) in health care [1,2]. Descriptive
systems are increasingly being used in this context
because of their ability to provide “off the shelf”
tariff values for a wide variety of generic health
states which can then be used in any CUA without
the requirement for collection of primary data to
elicit health state values [3–5]. The EuroQol instru-
ment (EQ-5D) represents one such descriptive sys-
tem which has been applied in a variety of health-
care settings throughout Europe [5,6]. Typically,
patients are asked to complete the EQ-5D and their
responses are converted to scores using a set of pre-
determined values generated from a representative
sample of the general population.
The majority of CUA studies relate to an
extended time period and typically health-related
quality of life (HRQL) of patients needs to be
assessed at several time points during the course of
follow-up, often by means of a self completion
questionnaire. In such studies it is common for a
proportion of HRQL data to be missing.
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Responses missing at a particular time point (
 
t
 
) can
be categorized in three main ways [7]. First,
responses may be missing completely at random,
where the probability of response at time 
 
t
 
 is inde-
pendent of both the previously observed value and
the unobserved value at time 
 
t
 
 and other variables
collected at this, or previous, time points, for
example measures of disease severity. Second,
responses may be missing at random where the
probability of response at time 
 
t
 
 depends on the
previously observed value or other variables col-
lected during the study but not the unobserved val-
ues at time t. The third category of missing
response is nonignorable nonresponse when the
probability of response at time t depends on the
unobserved  values  at  time  t  and  possibly  on
the previously observed values also.
Where the intervention being considered involves
treatment for a severe condition, as is the case with
liver transplantation, patients may be very ill before
receiving the intervention and it is common for a
proportion of participants to fail to complete ques-
tionnaires because of the severity of their illness or
death at any time point. Such data represent non-
ignorable nonresponse because the missing data
are directly dependent on the health status of the
patient. It is also common for a proportion of
patients to choose not to respond to the question-
naire at one or multiple time points. Such data may
be assumed to be missing completely at random
because the probability of response is independent
of any previously observed values.
A recent report on methods for the analysis of
quality of life and survival data in health technol-
ogy assessment recommended that methods for
the longitudinal analysis of quality of life data
allow for informative dropout [8]. This article
investigates the impact on the results obtained of
imputing health state values for patients who
dropped out of a study for informative reasons or
for those who chose not to respond to the ques-
tionnaire at one or more time points. This study
draws on data from a broader study to assess the
HRQL of liver transplant recipients pre- and post-
transplantation, undertaken within the context of
an economic evaluation of the liver transplanta-
tion program in England and Wales [9]. The
majority of studies undertaken to date which have
focused on the HRQL of liver transplant recipi-
ents have reported dramatic improvement after
liver transplantation [9–11]. Nevertheless, no pre-
vious studies in this area have considered the
impact of informative dropout or nonresponse on
the results obtained.
 
Methods
 
Information on HRQL and sociodemographic data
were collected using a postal questionnaire. Within
the questionnaire, individuals were asked to com-
plete the EQ-5D, a nondisease speciﬁc instrument
for describing and subsequently valuing HRQL
[5,6]. It is the responses to this ﬁrst part of the EQ-
5D that forms the basis for the analysis reported
here. Respondents are asked to categorize their
health status on ﬁve dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/
depression), where each dimension has three possi-
ble levels of response. A value for each health state
(possible combinations of dimension levels) was
derived from a representative sample of the UK gen-
eral population using the time trade-off method to
elicit preferences [12].
The population of interest was all individuals
who were selected to receive a liver transplant as
part of the National Health Service (NHS) liver
transplantation program at each of the Department
of Health designated centers in England and Wales
during a 12-month recruitment period, from 1995
to 1996 (n 
 
=
 
 400). The questionnaire was adminis-
tered at regular time intervals during the course of
their treatment. The majority of patients were sur-
veyed at the point of their being listed for liver
transplantation and at 3 months and 6 months after
listing. The vast majority of patients were trans-
planted at between 2 and 6 months after listing.
Very few patients waited more than 6 months to
receive their transplant. The questionnaire was also
administered to all eligible transplanted patients at
3 months, 6 months, 12 months, and 24 months
post-transplantation (n 
 
=
 
 387). At each time point,
patients who, in the opinion of a clinical research
nurse based at the center, were too severely ill to be
approached were not sent a questionnaire. One
reminder was sent to all nonrespondents at each
time interval, approximately three weeks after the
administration of the initial questionnaire. Individ-
uals in the survey were asked to complete the EQ-
5D from the perspective of their own health today.
At every time point, each individuals’ responses to
the ﬁve dimensions of the EQ-5D were converted to
a single value using the tariff of mean values for
health states produced by the York Measurement
and Valuation of Health (MVH) survey for the EQ-
5D, based on the time trade-off scaling technique
[13].
The EQ-5D values data were analyzed using sev-
eral different approaches and comparisons were
then made between the results generated using each
 Informative Dropout and Nonresponse Impact
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approach. In the base case analysis (A) no adjust-
ment was undertaken to allow for informative
dropout or nonresponse. In the second analysis (B)
an allowance was made for informative dropout
only, by giving all patients who died pretransplant
an EQ-5D tariff score of 0 and all patients who
became too ill an EQ-5D tariff score which corre-
sponded to the score attributable to the 5th percen-
tile of respondents for each subsequent time point
pretransplantation. The choice of the 5th percentile
was essentially arbitrary but, of the data that were
available, was considered to be most broadly repre-
sentative of respondents who were most ill.
Similarly, all patients who died post-transplant
were given an EQ-5D tariff score of 0 and all
patients who became too ill an EQ-5D tariff score
attributable to the 5th percentile of respondents for
each subsequent time point(s) post-transplantation.
In the third (method C), fourth (method D), and
ﬁfth (method E) analyses an allowance was made
for nonresponse only using alternative methods. A
distinction was made between individuals who
never responded to the survey and those who did
not respond or whose responses were unusable
because of an incomplete response at one or more
time points. The upper (C) and lower (D) conﬁ-
dence intervals (CI) around the mean EQ-5D tariff
score for each time-point for responders were
attributed to those patients who never responded.
For those patients who responded at some but not
all time-points, the approach adopted was to
impute using the last known value carried forward.
In method E, the more sophisticated statistical tech-
nique of multiple imputation (MI) was used to esti-
mate values for nonresponders at each time interval.
MI is a Monte Carlo simulation technique where
each missing data case is replaced by a set of plau-
sible estimates, which are drawn from the predictive
distribution of the missing data given the observed
data. In contrast to the more naïve approaches, the
technique of MI has the advantage that it includes a
random component to reﬂect the fact that imputed
values are estimated rather than treating the
imputed values as if they are known with certainty.
As such, MI is likely to produce more accurate esti-
mates of the standard errors (SE) and variances of
the mean utility values at each time-point than other
methods of imputation [14]. A priori this was our
preferred approach for handling missing data
because of nonresponse.
The data were assumed to follow a multivariate
normal distribution and multiple imputation was
carried out. The predictive distribution reﬂects the
uncertainty about the missing data. The number of
estimates required is determined by the rate of miss-
ing information for the quantity being estimated
[10]. In this study the rate of missing information
determined that ﬁve estimates were required. The
missing EQ-5D scores were estimated taking into
account the time-point of questionnaire administra-
tion and the characteristics of each of the nonre-
sponders, including their age, sex, and type of liver
disease, and matching them to equivalent individu-
als in the group of responders. Each completed data
set was then separately analyzed using complete
data statistics and the results (mean estimates and
standard deviations) were combined using simple
rules developed by Rubin to produce overall mean
estimates and standard deviations reﬂecting missing
data uncertainty because of nonresponse [15].
The data were analyzed using the statistical pack-
age SPSS version 10 [16] and the computer software
package NORM [17], was used for multiple impu-
tation. All of the statistical tests used in the analysis
were parametric. To determine differences in EQ-
5D scores between each time point, a repeated
measures analysis of variance was performed.
 
Results
 
During the course of the study, two patient groups
accounted for missing data, the ﬁrst led to inform-
ative dropout and the second led to nonresponse.
Within the informative dropout group, 31 individ-
uals became too ill to complete the questionnaire at
some time point, of whom 12 individuals subse-
quently died, and 81 individuals dropped out of the
study because death. Within the nonresponse
group, 114 individuals chose not to respond to the
questionnaire at one or more time intervals and 16
individual’s responses were unusable as they were
incomplete. The survey population, respondents,
and nonrespondents by time-point are presented in
Table 1.
The results of the analyses of the pretransplant
data for dependent samples are presented in
Table 2 (and graphically in Fig. 1). A comparison
of mean EQ-5D pretransplant scores at listing and
3 months after listing in the base case analysis (A)
revealed a deterioration in HRQL between listing
and 3 months after listing. Adjusting for informa-
tive dropout in isolation (Method B) resulted in a
marked deterioration in mean scores over time
pretransplant relative to the base case situation in
which no such adjustments were made. Neverthe-
less, adjusting for informative dropout and/or non-
response, regardless of the mechanism used to
adjust for nonresponse, did not alter the base-case
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conclusion of no statistically signiﬁcant dif-
ferences in mean EQ-5D scores over time
pretransplant.
Comparisons of dependent samples post-trans-
plant (Table 3 and Fig. 2) showed highly statisti-
cally signiﬁcant improvements over time when no
allowance for informative dropout was made
(method A, P < 0.001). In marked contrast, no sta-
tistically signiﬁcant improvements over time were
found when informative dropout was allowed for
(method B, P = 0.402). Allowing for nonresponders
in isolation (methods B, C, and E) reinforced the
ﬁndings of the main analysis regardless of the meth-
ods used to impute EQ-5D scores for nonrespond-
ers. Simultaneous adjustment for informative
dropout and nonresponse (methods B + C, B + D,
and B + E) resulted in no statistically signiﬁcant
improvements in mean EQ-5D scores post-trans-
plant regardless of the methods used to impute
scores for nonresponders.
 
Table 1
 
Survey population, respondents, and nonresponders by time-point
 
Time point
Total eligible
population
No. of
patients 
from total 
eligible
population
omitted as
too ill
No. of
patients from 
total eligible
population
omitted 
because
of  death
No. of
quests
sent out
No. of
quests not
returned or
unusable
(missing data)
Useable 
responses  
N (%) relative  
to the total 
eligible 
population
Listing 400 17 0 383 104 74%
3 months after listing 119* 7 2 110 37 69%
3 months after transplant 387
 
†
 
2 22 363 78 80%
6 months after transplant 387 2 39 346 86 78%
12 months after transplant 387 0 55 332 60 84%
24 months after transplant 387 0 69 298 80 79%
 
*Of the patients listed, 281 had been transplanted by 3 months.
 
†
 
Of  the 400 patients listed, 13 were delisted before transplantation.
 
Table 2
 
Comparison of  mean EQ-5D pretransplant scores
over time (Repeated measures analysis of  variance) at listing
and 3 months after listing
 
Method
Listing mean
95% CI (N)
3 months  
after listing 
mean 95%
CI (N)
 
P
 
-value
A: (unadjusted 0.462 0.365 0.077
analysis) 0.422–0.502
(279)
0.274–0.456
(73)
B: (adjusting for 0.428 0.329 0.081
informative dropout) 0.387–0.469 0.245–0.413
(296) (82)
C: (nonresponders 0.473 0.396 0.184
upper 95% CI) 0.444–0.502 0.345–0.446
(383) (110)
D: (nonresponders 0.451 0.334 0.190
lower 95% CI) 0.420–0.480 0.280–0.388
(383) (110)
E: (nonresponders 0.470 0.382 0.064
missing imputation) 0.436–0.510 0.335–0.405
(383) (110)
B + C: (adjusting for
informative dropout
+ nonresponders
upper 95% CI)
0.459
0.429–0.488
(400)
0.372
0.320–0.424
(119)
0.069
B + D: (adjusting for
informative dropout
+ nonresponders
lower 95% CI)
0.438
0.408–0.468
(400)
0.361
0.309–0.413
(119)
0.072
B 
 
+
 
 E: (adjusting for
informative dropout
 
+
 
 nonresponders
multiple imputation)
0.456
0.415–0.494
(400)
0.368
0.284–0.449
(119)
0.093
 
Figure 1
 
Comparison of  mean EQ-5D scores pretransplant.
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Comparison of  mean EQ-5D scores post-transplant.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
A B A + C A + D A + E B + C B + D B + E
Method
M
ea
n
 
EQ
-
5D
 
sc
o
re
3
6
12
24
 Informative Dropout and Nonresponse Impact
 
57
 
Discussion
 
This study has highlighted the marked differences
which can occur in mean utility values within lon-
gitudinal studies when proper allowance is made for
informative dropout and/or nonresponse relative to
a situation in which such adjustments are not made.
The majority of studies undertaken to date which
have focused on the HRQL of liver transplant recip-
ients have reported dramatic improvement after
liver transplantation, despite the possibility of prob-
lems post-transplant including rejection, infection,
and the side effects of lifelong immunosuppression
[8,14,15]. The results from our base case analysis
mirror the ﬁndings of previous studies in that, in
general, HRQL after liver transplantation improves
dramatically relative to the pretransplant situation.
Whilst such analyses typically provide a detailed
descriptive proﬁle of the quality of life of the
respondents, they do not provide a full account of
the quality of life experience of all patients who
have received the intervention.
In relation to the informative dropout group,
such data represent nonignorable nonresponse
because the missing data are directly dependent on
the health status of the patient. Where informative
dropout is not accounted for, the responses achieved
are likely to be biased upwards because of the
absence of any extremely low values. The extent of
the bias achieved is dependent on the proportion of
patients within the overall sample who drop out
of the study because of death or severe ill health. In
this study allowing for informative dropout resulted
in a marked reduction in mean EQ-5D scores over
time post-transplant and effectively canceled out the
steady improvement in HRQL over time reported in
the base case.
In relation to the nonresponse group, the
data are assumed to be missing completely at ran-
dom. Allowing for nonresponse in isolation resulted
in similar mean EQ-5D scores to those achieved in
the base case, regardless of the method of imputa-
tion used. Nevertheless, naive methods of correcting
for nonresponse (e.g., upper and lower 95% CI
around the mean, methods C and D) assume that all
nonresponders would have responded in a similar
fashion to respondents, thereby producing broadly
equivalent estimates of utility, with little estimated
variance. The uncertainties involved in the estima-
tion of these utility values are ignored. MI has the
advantage that it includes a random component to
reﬂect the fact that imputed values are estimated
rather than treating the imputed values as if they are
known with certainty. Thus, the technique of MI
accounts for the amount of uncertainty involved in
the imputation of missing values. This thereby pro-
 
Table 3
 
Comparison of  mean EQ-5D post-transplant scores over time (Repeated measures analysis of  variance) at 3, 6, 12, and
24 months post-transplant
 
 
 
Method
3 months
post-
transplant
mean
95% CI
(N)
6 months
post-
transplant
mean
95% CI
(N)
12 months
post-
transplant
mean
95% CI
(N)
24 months 
post- 
transplant 
mean 
95% CI 
(N)
 
P
 
-value
A: (unadjusted analysis) 0.636
0.605–0.667
(285)
0.689
0.657–0.721
(260)
0.717
0.687–0.747
(272)
0.725
0.688–0.762
(218)
 
<
 
0.001
B: (adjusting for informative dropout) 0.574
0.534–0.617
(309)
0.595
0.549–0.638
(301)
0.601
0.560–0.642
(327)
0.569
0.506–0.629
(287)
0.402
C: (nonresponders upper 95% CI) 0.644
0.624–0.669
(363)
0.697
0.669–0.721
(346)
0.722
0.697–0.747
(332)
0.733
0.698–0.762
(298)
 
<
 
0.001
D: (nonresponders lower 95% CI) 0.632
0.604–0.656
(363)
0.683
0.658–0.708
(340)
0.714
0.682–0.739
(332)
0.718
0.688–0.749
(298)
 
<
 
0.001
E: (nonresponders missing imputation) 0.635
0.601–0.672
(363)
0.686
0.640–0.711
(340)
0.719
0.685–0.741
(332)
0.730
0.663–0.744
(298)
 
<
 
0.001
B + C: (adjusting for informative dropout
+ nonresponders upper 95% CI)
0.586
0.559–0.613
(387)
0.610
0.580–0.640
(387)
0.635
0.592–0.667
(387)
0.625
0.580–0.661
(387)
0.169
B + D: (adjusting for informative dropout
+ nonresponders lower 95% CI)
0.569
0.542–0.596
(387)
0.593
0.563–0.623
(387)
0.618
0.605–0.676
(387)
0.603
0.551–0.648
(387)
0.105
B + E: (adjusting for informative dropout
+ nonresponders multiple imputation)
0.576
0.538–0.602
(387)
0.601
0.572–0.641
(387)
0.626
0.589–0.661
(387)
0.629
0.540–0.776
(387)
0.185
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duces a more accurate estimate of the SE and vari-
ances of the mean utility values at each time-point.
To provide a full account of the quality of life
experience of all patients, it is important that future
studies which purport to assess the HRQL over time
of patients with end-stage liver disease and other
chronic conditions include an allowance for inform-
ative dropout and nonresponse within the analysis.
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